Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The SGLT2 inhibitor empagliflozin improves the primary di... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
0
Authors
Sebastian Steven
18 more
Sebastian Steven
•
Thomas Münzel
16 more
•
Andreas Daiber
Published
June 23, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Redox Biology
Topics
Chemistry
Internal Medicine
Medicine
Endocrinology
Organic Chemistry
Show all topics
DOI
10.1016/j.redox.2017.06.009
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Redox Biology
Topics
Chemistry
Internal Medicine
Medicine
Endocrinology
Organic Chemistry
Show all topics
DOI
10.1016/j.redox.2017.06.009
License
CC-BY-NC-ND
Other Formats
PDF
